Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.

Using MRI to Identify Supranuclear Palsy from Parkinson Disease and Dementia with Lewy Bodies.

Shah GV.

Radiology. 2019 Dec;293(3):654-655. doi: 10.1148/radiol.2019192183. Epub 2019 Oct 15. No abstract available.

PMID:
31617819
2.

Calcitonin induces stem cell-like phenotype in prostate cancer cells.

Aldahish A, Kale A, Aljameeli A, Shah GV.

Endocr Relat Cancer. 2019 Nov;26(11):815-828. doi: 10.1530/ERC-19-0333.

PMID:
31561211
3.

Artery of Percheron Infarct: 12 Cases and Their Complex Clinical Courses.

Stamm BJ, Lineback CM, Skolarus LE, Morgenstern LB, Shah GV.

Neurohospitalist. 2018 Jul;8(3):141-145. doi: 10.1177/1941874417748543. Epub 2017 Dec 28.

4.

Calcitonin Receptor-Zonula Occludens-1 Interaction Is Critical for Calcitonin-Stimulated Prostate Cancer Metastasis.

Aljameeli A, Thakkar A, Thomas S, Lakshmikanthan V, Iczkowski KA, Shah GV.

PLoS One. 2016 Mar 2;11(3):e0150090. doi: 10.1371/journal.pone.0150090. eCollection 2016.

5.

Probability of developing proximal deep-vein thrombosis and/or pulmonary embolism after distal deep-vein thrombosis.

Brateanu A, Patel K, Chagin K, Tunsupon P, Yampikulsakul P, Shah GV, Wangsiricharoen S, Amah L, Allen J, Shapiro A, Gupta N, Morgan L, Kumar R, Nielsen C, Rothberg MB.

Thromb Haemost. 2016 Mar;115(3):608-14. doi: 10.1160/TH15-06-0503. Epub 2015 Dec 10.

PMID:
26660731
6.

Measurement of serum prostate cancer markers using a nanopore thin film based optofluidic chip.

Alzghoul S, Hailat M, Zivanovic S, Que L, Shah GV.

Biosens Bioelectron. 2016 Mar 15;77:491-8. doi: 10.1016/j.bios.2015.10.006. Epub 2015 Oct 9.

7.

A-kinase anchoring protein 2 is required for calcitonin-mediated invasion of cancer cells.

Thakkar A, Aljameeli A, Thomas S, Shah GV.

Endocr Relat Cancer. 2016 Jan;23(1):1-14. doi: 10.1530/ERC-15-0425. Epub 2015 Oct 2.

8.

Sonographically guided lumbar puncture in pediatric patients.

Wang PI, Wang AC, Naidu JO, Dipietro MA, Sundgren PC, Quint DJ, Parmar HA, Shah GV, Muraszko KM, Srinivasan A.

J Ultrasound Med. 2013 Dec;32(12):2191-7. doi: 10.7863/ultra.32.12.2191.

9.

Case based learning: a method for better understanding of biochemistry in medical students.

Nair SP, Shah T, Seth S, Pandit N, Shah GV.

J Clin Diagn Res. 2013 Aug;7(8):1576-8. doi: 10.7860/JCDR/2013/5795.3212. Epub 2013 Aug 1.

10.

Utility of dual-energy CT virtual keV monochromatic series for the assessment of spinal transpedicular hardware-bone interface.

Srinivasan A, Hoeffner E, Ibrahim M, Shah GV, LaMarca F, Mukherji SK.

AJR Am J Roentgenol. 2013 Oct;201(4):878-83. doi: 10.2214/AJR.12.9736.

PMID:
24059379
11.

Differentiation of benign and malignant neck pathologies: preliminary experience using spectral computed tomography.

Srinivasan A, Parker RA, Manjunathan A, Ibrahim M, Shah GV, Mukherji SK.

J Comput Assist Tomogr. 2013 Sep-Oct;37(5):666-72. doi: 10.1097/RCT.0b013e3182976365.

PMID:
24045238
12.

Profiling of the calcitonin-calcitonin receptor axis in primary prostate cancer: clinical implications and molecular correlates.

Thakkar A, Bijnsdorp IV, Geldof AA, Shah GV.

Oncol Rep. 2013 Sep;30(3):1265-74. doi: 10.3892/or.2013.2583. Epub 2013 Jul 2.

13.

Postoperative and postradiation changes on imaging.

Lobert P, Srinivasan A, Shah GV, Mukherji SK.

Otolaryngol Clin North Am. 2012 Dec;45(6):1405-22. doi: 10.1016/j.otc.2012.08.009. Epub 2012 Sep 26. Review.

PMID:
23153755
14.

Cervical lymph node evaluation and diagnosis.

Bryson TC, Shah GV, Srinivasan A, Mukherji SK.

Otolaryngol Clin North Am. 2012 Dec;45(6):1363-83. doi: 10.1016/j.otc.2012.08.007. Review.

PMID:
23153753
15.

Imaging in infections of the head and neck.

Hegde AN, Mohan S, Pandya A, Shah GV.

Neuroimaging Clin N Am. 2012 Nov;22(4):727-54. doi: 10.1016/j.nic.2012.05.007. Epub 2012 Aug 11.

PMID:
23122264
16.

Central nervous system tuberculosis: pathophysiology and imaging findings.

Patkar D, Narang J, Yanamandala R, Lawande M, Shah GV.

Neuroimaging Clin N Am. 2012 Nov;22(4):677-705. doi: 10.1016/j.nic.2012.05.006. Epub 2012 Aug 11. Review.

PMID:
23122262
17.

Imaging of cerebritis, encephalitis, and brain abscess.

Rath TJ, Hughes M, Arabi M, Shah GV.

Neuroimaging Clin N Am. 2012 Nov;22(4):585-607. doi: 10.1016/j.nic.2012.04.002. Epub 2012 Sep 28. Review.

PMID:
23122258
18.

Imaging of meningitis and ventriculitis.

Mohan S, Jain KK, Arabi M, Shah GV.

Neuroimaging Clin N Am. 2012 Nov;22(4):557-83. doi: 10.1016/j.nic.2012.04.003. Epub 2012 Sep 4. Review.

PMID:
23122257
19.

Central retinal artery occlusion secondary to orbital inflammation in lupus erythematosus profundus.

Sudhakar P, Shah GV, Saponara F, Fullen DR, Trobe JD.

J Neuroophthalmol. 2012 Mar;32(1):93-4. doi: 10.1097/WNO.0b013e31823f8548. No abstract available.

PMID:
22190062
20.

Incidental findings on cranial imaging in nonagenarians.

Al-Holou WN, Khan A, Wilson TJ, Stetler WR Jr, Shah GV, Maher CO.

Neurosurg Focus. 2011 Dec;31(6):E11. doi: 10.3171/2011.9.FOCUS11205.

PMID:
22133167
21.

Methods for evaluation of structural and biological properties of antiinvasive natural products.

Mudit M, Khanfar M, Shah GV, Sayed KA.

Methods Mol Biol. 2011;716:55-71. doi: 10.1007/978-1-61779-012-6_4.

PMID:
21318900
22.

Natalizumab (Tysabri).

Selewski DT, Shah GV, Segal BM, Rajdev PA, Mukherji SK.

AJNR Am J Neuroradiol. 2010 Oct;31(9):1588-90. doi: 10.3174/ajnr.A2226. Epub 2010 Aug 5. Review.

23.

Rituximab (Rituxan).

Selewski DT, Shah GV, Mody RJ, Rajdev PA, Mukherji SK.

AJNR Am J Neuroradiol. 2010 Aug;31(7):1178-80. doi: 10.3174/ajnr.A2142. Epub 2010 May 6. Review.

24.

A new mixed-backbone oligonucleotide against glucosylceramide synthase sensitizes multidrug-resistant tumors to apoptosis.

Patwardhan GA, Zhang QJ, Yin D, Gupta V, Bao J, Senkal CE, Ogretmen B, Cabot MC, Shah GV, Sylvester PW, Jazwinski SM, Liu YY.

PLoS One. 2009 Sep 9;4(9):e6938. doi: 10.1371/journal.pone.0006938.

25.

Management and outcomes of patients undergoing surgery for traumatic cervical fracture-subluxation associated with an asymptomatic vertebral artery injury.

Sack JA, Etame AB, Shah GV, La Marca F, Park P.

J Spinal Disord Tech. 2009 Apr;22(2):86-90. doi: 10.1097/BSD.0b013e318167a81e.

PMID:
19342928
26.

Identification of a small molecule class to enhance cell-cell adhesion and attenuate prostate tumor growth and metastasis.

Shah GV, Muralidharan A, Thomas S, Gokulgandhi M, Mudit M, Khanfar M, El Sayed K.

Mol Cancer Ther. 2009 Mar;8(3):509-20. doi: 10.1158/1535-7163.MCT-08-0693. Epub 2009 Mar 10.

27.

Discovery, design, and synthesis of anti-metastatic lead phenylmethylene hydantoins inspired by marine natural products.

Mudit M, Khanfar M, Muralidharan A, Thomas S, Shah GV, van Soest RW, El Sayed KA.

Bioorg Med Chem. 2009 Feb 15;17(4):1731-8. doi: 10.1016/j.bmc.2008.12.053. Epub 2008 Dec 29. Erratum in: Bioorg Med Chem. 2009 Apr 15;17(8):3216-7.

PMID:
19195897
28.

Cadherin switching and activation of beta-catenin signaling underlie proinvasive actions of calcitonin-calcitonin receptor axis in prostate cancer.

Shah GV, Muralidharan A, Gokulgandhi M, Soan K, Thomas S.

J Biol Chem. 2009 Jan 9;284(2):1018-30. doi: 10.1074/jbc.M807823200. Epub 2008 Nov 9.

29.

Calcitonin promotes in vivo metastasis of prostate cancer cells by altering cell signaling, adhesion, and inflammatory pathways.

Shah GV, Thomas S, Muralidharan A, Liu Y, Hermonat PL, Williams J, Chaudhary J.

Endocr Relat Cancer. 2008 Dec;15(4):953-64. doi: 10.1677/ERC-08-0136. Epub 2008 Sep 10.

PMID:
18784182
30.

New directions in head and neck imaging.

Shah GV, Wesolowski JR, Ansari SA, Mukherji SK.

J Surg Oncol. 2008 Jun 15;97(8):644-8. doi: 10.1002/jso.21022. Review.

31.

Calcifying pseudoneoplasm of the spine.

Park P, Schmidt LA, Shah GV, Tran NK, Gandhi D, La Marca F.

Clin Neurol Neurosurg. 2008 Apr;110(4):392-5. doi: 10.1016/j.clineuro.2007.12.006. Epub 2008 Feb 1.

PMID:
18242822
32.

Biocatalytic and semisynthetic optimization of the anti-invasive tobacco (1S,2E,4R,6R,7E,11E)-2,7,11-cembratriene-4,6-diol.

El Sayed KA, Laphookhieo S, Baraka HN, Yousaf M, Hebert A, Bagaley D, Rainey FA, Muralidharan A, Thomas S, Shah GV.

Bioorg Med Chem. 2008 Mar 15;16(6):2886-93. doi: 10.1016/j.bmc.2007.12.056. Epub 2008 Jan 3.

PMID:
18222089
33.

Knock-down of calcitonin receptor expression induces apoptosis and growth arrest of prostate cancer cells.

Thomas S, Muralidharan A, Shah GV.

Int J Oncol. 2007 Dec;31(6):1425-37.

PMID:
17982669
35.

Squamous Cell Carcinoma: Initial Diagnosis and Staging with PET/CT.

Shah GV, Wong KK, Gandhi D, Parmar H, Mukherji SK.

PET Clin. 2007 Oct;2(4):469-80. doi: 10.1016/j.cpet.2008.06.003. Epub 2008 Oct 10. Review.

PMID:
27158107
36.

Calcitonin receptor-stimulated migration of prostate cancer cells is mediated by urokinase receptor-integrin signaling.

Thomas S, Chiriva-Internati M, Shah GV.

Clin Exp Metastasis. 2007;24(5):363-77. Epub 2007 May 9.

PMID:
17487556
37.

The predominant CD44 splice variant in prostate cancer binds fibronectin, and calcitonin stimulates its expression.

Iczkowski KA, Omara-Opyene AL, Shah GV.

Anticancer Res. 2006 Jul-Aug;26(4B):2863-72.

38.

Peripheral primitive neuroectodermal tumor/Ewing's sarcoma of the craniospinal vault: case reports and review.

Mobley BC, Roulston D, Shah GV, Bijwaard KE, McKeever PE.

Hum Pathol. 2006 Jul;37(7):845-53. Epub 2006 May 19. Review.

PMID:
16784984
39.

Paracrine calcitonin in prostate cancer is linked to CD44 variant expression and invasion.

Iczkowski KA, Omara-Opyene AL, Kulkarni TR, Pansara M, Shah GV.

Anticancer Res. 2005 May-Jun;25(3B):2075-83.

40.

Calcitonin increases invasiveness of prostate cancer cells: role for cyclic AMP-dependent protein kinase A in calcitonin action.

Sabbisetti VS, Chirugupati S, Thomas S, Vaidya KS, Reardon D, Chiriva-Internati M, Iczkowski KA, Shah GV.

Int J Cancer. 2005 Nov 20;117(4):551-60.

41.

Magnetic resonance imaging of suspected cervicocranial arterial dissections.

Shah GV, Quint DJ, Trobe JD.

J Neuroophthalmol. 2004 Dec;24(4):315-8.

PMID:
15662248
42.

Targeted overexpression of calcitonin in gonadotrophs of transgenic mice leads to chronic hypoprolactinemia.

Yuan R, Kulkarni T, Wei F, Shah GV.

Mol Cell Endocrinol. 2005 Jan 14;229(1-2):193-203.

PMID:
15607543
43.

MR imaging of salivary glands.

Shah GV.

Neuroimaging Clin N Am. 2004 Nov;14(4):777-808.

PMID:
15489152
44.

MR imaging of brachial plexus.

Todd M, Shah GV, Mukherji SK.

Top Magn Reson Imaging. 2004 Apr;15(2):113-25. Review.

PMID:
15269614
45.

Magnetic resonance spectroscopy of head and neck neoplasms.

Shah GV, Gandhi D, Mukherji SK.

Top Magn Reson Imaging. 2004 Apr;15(2):87-94. Review.

PMID:
15269611
46.

Dynamic contrast-enhanced MR imaging.

Shah GV, Fischbein NJ, Gandhi D, Mukherji SK.

Top Magn Reson Imaging. 2004 Apr;15(2):71-7. Review.

PMID:
15269609
47.

Metastatic neuroblastoma presenting with binocular blindness from intracranial compression of the optic nerves.

Lau JJ, Trobe JD, Ruiz RE, Cho RW, Wechsler DS, Shah GV, Gebarski SS.

J Neuroophthalmol. 2004 Jun;24(2):119-24.

PMID:
15179064
48.

Cerebral perfusion CT: technique and clinical applications.

Hoeffner EG, Case I, Jain R, Gujar SK, Shah GV, Deveikis JP, Carlos RC, Thompson BG, Harrigan MR, Mukherji SK.

Radiology. 2004 Jun;231(3):632-44. Epub 2004 Apr 29. Review.

PMID:
15118110
49.

Prostate cancer invasion is influenced more by expression of a CD44 isoform including variant 9 than by Muc18.

Omara-Opyene AL, Qiu J, Shah GV, Iczkowski KA.

Lab Invest. 2004 Jul;84(7):894-907.

50.

Newer MR imaging techniques for head and neck.

Shah GV, Fischbein NJ, Patel R, Mukherji SK.

Magn Reson Imaging Clin N Am. 2003 Aug;11(3):449-69, vi. Review.

PMID:
14768729

Supplemental Content

Support Center